glp-1 receptor agonists for type 2 diabetes PDB-101: Molecule of the Month: GLP1 Receptor Agonists—Effects beyond Obesity

Forum Health offers IV therapy at multiple clinic locations, delivered by licensed practitioners trained in functional and integrative medicine

Animal model studies suggest anxiolytic and antidepressant effects, possibly mediated through interaction with the dopaminergic and serotonergic systems

PLoS ONE 13:e0198373

Research has connected it with improved skin density, regenerative aesthetics, visible changes, and potentially reducing wrinkles through long-term tissue remodeling.

Its antioxidant action is not direct free-radical scavenging but rather upregulation of superoxide dismutase and catalase activity, which is a mechanistically distinct and potentially more durable form of antioxidant defense